BMP Pharma Trading AG
XBER:BMP
Balance Sheet
Balance Sheet Decomposition
BMP Pharma Trading AG
BMP Pharma Trading AG
Balance Sheet
BMP Pharma Trading AG
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
12
|
11
|
9
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
5
|
7
|
8
|
|
| Accounts Receivables |
12
|
11
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
2
|
2
|
2
|
0
|
2
|
5
|
0
|
0
|
|
| Inventory |
4
|
3
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
17
|
17
|
16
|
2
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
2
|
5
|
7
|
8
|
|
| PP&E Net |
2
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
2
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
5
|
5
|
5
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
21
N/A
|
24
+13%
|
22
-7%
|
6
-72%
|
5
-17%
|
5
-9%
|
4
-6%
|
4
-1%
|
5
+7%
|
4
-5%
|
5
+2%
|
5
+8%
|
5
+0%
|
5
+10%
|
5
+2%
|
6
+1%
|
6
+8%
|
6
+6%
|
7
+8%
|
10
+42%
|
12
+22%
|
13
+8%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
4
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
9
|
8
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
13
|
14
|
13
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Long-Term Debt |
1
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
|
| Total Liabilities |
15
N/A
|
19
+28%
|
18
-7%
|
0
-100%
|
0
N/A
|
1
+1 300%
|
1
+1%
|
1
-7%
|
1
-41%
|
0
-69%
|
0
-21%
|
0
+27%
|
0
-16%
|
0
+53%
|
0
+36%
|
0
+17%
|
0
+3%
|
0
+15%
|
1
+80%
|
1
+46%
|
3
+184%
|
4
+31%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Retained Earnings |
1
|
0
|
0
|
1
|
0
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
4
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
4
-24%
|
4
-3%
|
6
+43%
|
5
-17%
|
4
-30%
|
3
-9%
|
3
+1%
|
4
+22%
|
4
+5%
|
4
+3%
|
5
+7%
|
5
+1%
|
5
+8%
|
5
0%
|
5
+0%
|
6
+9%
|
6
+6%
|
6
+3%
|
9
+41%
|
9
+1%
|
9
+3%
|
|
| Total Liabilities & Equity |
21
N/A
|
24
+13%
|
22
-7%
|
6
-72%
|
5
-17%
|
5
-9%
|
4
-6%
|
4
-1%
|
5
+7%
|
4
-5%
|
5
+2%
|
5
+8%
|
5
+0%
|
5
+10%
|
5
+2%
|
6
+1%
|
6
+8%
|
6
+6%
|
7
+8%
|
10
+42%
|
12
+22%
|
13
+8%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|